Evidence map›Paper›PMID 19004936›Full record

ArticleJournal of virology2009

The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes.

Atasi Poddar, Shawna C Reed, Maria G McPhillips, Jonathan E Spindler, Alison A McBride

Abstract read
In one paragraph

Article in Journal of virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Viral remodeling of the 4D nucleome.Experimental & molecular medicine · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Atasi PoddarLaboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland 20892, USA.
Shawna C Reed
Maria G McPhillips
Jonathan E Spindler
Alison A McBride
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

Genome Replication and Partitioning of Beta PapillomavirusesZIAAI001072 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MCBRIDE, ALISON · 2009 to 2016
$1.4M
Genome Replication and Partitioning of Beta PapillomavirusesZ01AI001072 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MCBRIDE, ALISON · 2008 to 2008
$339k
6 · The paper itself

Abstract

For many papillomaviruses, the viral protein E2 tethers the viral genome to the host mitotic chromosomes to ensure persistent, long-term maintenance of the genome during cell division. Our previous studies of E2 proteins from different genera of papillomaviruses have shown that they bind to different regions of the host chromosomes during mitosis. For example, bovine papillomavirus type 1 (BPV-1) E2 binds to all chromosomes as small speckles in complex with the cellular protein Brd4. In contrast, the human papillomavirus type 8 (HPV-8) E2 protein binds as large speckles at the pericentromeric regions of chromosomes. Here we show that these speckles do not contain Brd4, and unlike that of BPV-1, the N-terminal Brd4-interacting domain of HPV-8 E2 is not required for chromosome binding. In contrast to BPV-1 E2, the HPV-8 E2 protein targets the short arms of acrocentric mitotic chromosomes. Furthermore, the E2 protein interacts with the repeated ribosomal DNA genes found in this location and colocalizes with UBF, the RNA polymerase I transcription factor. Therefore, HPV-8 E2 genome tethering occurs by a Brd4-independent mechanism through a novel interaction with specific regions of mitotic chromosomes. Thus, a wide range of viruses have adopted the strategy of linking their genomes to host chromosomes, but individual viruses use different chromosomal targets. Characterization of these targets will enable the development of antiviral therapies to eliminate the viral genomes from infected cells.

Indexed as

Virus ReplicationAnimalsBromodomain Containing ProteinsCell Cycle ProteinsCell LineChlorocebus aethiopsDNA, RibosomalHost-Pathogen InteractionsHumansNuclear ProteinsOncogene Proteins, ViralPapillomaviridaePol1 Transcription Initiation Complex ProteinsProtein BindingTrans-ActivatorsTranscription FactorsBRD4 protein, humanBromodomain Containing ProteinsCell Cycle ProteinsDNA, RibosomalNuclear Proteinsoncogene protein E2, Human papillomavirus type 8Oncogene Proteins, ViralPol1 Transcription Initiation Complex ProteinsTrans-ActivatorsTranscription Factorstranscription factor UBF

Identifiers

PMID19004936
PMCPMC2612381
OpenAlexW1975662029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.